≡
  1. Antibodies

Summary:

Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)
Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)

PAB364Hu01 | Homo sapiens (Human)

BRCA2; BRCC2; FACD; FAD; FAD1; FANCD; FANCD1; Breast Cancer 2,Early Onset; Breast Cancer Type 2 Susceptibility Protein; Fanconi anemia group D1 protein
Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)
Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)

PAB364Mu01 | Mus musculus (Mouse)

BRCA2; BRCC2; FACD; FAD; FAD1; FANCD; FANCD1; Breast Cancer 2,Early Onset; Breast Cancer Type 2 Susceptibility Protein; Fanconi anemia group D1 protein
Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)
Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)

PAB364Mu02 | Mus musculus (Mouse)

BRCA2; BRCC2; FACD; FAD; FAD1; FANCD; FANCD1; Breast Cancer 2,Early Onset; Breast Cancer Type 2 Susceptibility Protein; Fanconi anemia group D1 protein
Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)
Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)

PAB364Ra01 | Rattus norvegicus (Rat)

BRCA2; BRCC2; FACD; FAD; FAD1; FANCD; FANCD1; Breast Cancer 2,Early Onset; Breast Cancer Type 2 Susceptibility Protein; Fanconi anemia group D1 protein
1/1